|
|
Nephrology
Research Funding
Evaluation of Aquaporin 2 Excretion in Disorders of Water Balance
Principal Investigator: Melissa A. Cadnapaphornchai, MD
Source: National Institutes of Health, Clinical Investigator Development Award - 5K23DK027989-03
Term: 2000-2005
Angiopoietin-2 as a Modifier of Disease Severity in Autosomal Dominant Polycystic Kidney Disease (Pilot and Feasibility Study)
Principal Investigator: Melissa A. Cadnapaphornchai, MD
Source: The Children's Hospital Research Institute/ Pediatric Clinical
Translational Research Center
Term: 2005-2006
Antihypertensive Therapy in Children with Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Principal Investigators: Melissa A. Cadnapaphornchai, MD, and Robert Schrier, MD
Source: National Institutes of Health - R01 Award
Term: 2001-2006
Regulation, Release and Action of Vasopressin
Principal Investigators: Melissa A. Cadnapaphornchai, MD, and Robert Schrier, MD
Source:National Institutes of Health - P01 Award
Term: 2004-2009
North American Pediatric Renal Transplant Collaborative Study Registry
Principal Investigator: Gary M. Lum, MD
Source: Sandoz Drug Company
Term: 1990-Continuous
A Controlled Trial of Steroid Withdrawal in Pediatric Renal Transplant Recipients
Principal Investigator: Gary M. Lum, MD
Source: National Institutes of Health - A106134
Term: 1994-Indefinite
2003-2004
Evaluation of Aquaporin 2 Excretion in Disorders of Water Balance
Principal Investigator: Melissa A. Cadnapaphornchai, MD
Source: National Institutes of Health, Clinical Investigator Development Award - 5K23DK027989-03
Term: 2000-2005
Antihypertensive Therapy in Children with Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Principal Investigators: Melissa A. Cadnapaphornchai, MD, and Robert Schrier, MD
Source: National Institutes of Health - R01 Award
Term: 2001-2006
North American Pediatric Renal Transplant Collaborative Study Registry
Principal Investigator: Gary M. Lum, MD
Source: Sandoz Drug Company
Term: 1990-Continuous
A Controlled Trial of Steroid Withdrawal in Pediatric Renal Transplant Recipients
Principal Investigator: Gary M. Lum, MD
Source: National Institutes of Health - A106134
Term: 1994-Indefinite
2001-2002
Evaluation of Aquaporin 2 Excretion in Disorders of Water Balance
Principal Investigator: Melissa A. Cadnapaphornchai, MD
Source: National Institutes of Health, Clinical Investigator Development Award - 5K23DK027989-03
Term: 2000-2005
Synsorb Pk in Children with E. Coli-Associated Hemolytic Uremic Syndrome
Principal Investigator: Douglas M. Ford, MD
Source: Synsorb Biotech and National Institutes of Health
Term: 1997-2001
Lisinopril
Principal Investigator: Douglas M. Ford, MD
Source: Merck & Co., Inc.
Term: 2001
Safety and Efficacy of HRM4396 for the Management of Anemia in Pediatric Subjects with Chronic Renal Failure (Predialysis, Hemodialysis, Peritoneal Dialysis)
Principal Investigator: Douglas M. Ford, MD
Source: Aventis Pharmaceutical
Term: 2001
A Multicenter, Open-Label, Steady State Study to Evaluate the Pharmacokinetics of Benazepril in Pediatric Subjects 1 Month to 16 Years of Age
Principal Investigator: Douglas M. Ford, MD
Source: Novartis Pharmaceuticals Corporation
Term: 2002
North American Pediatric Renal Transplant Collaborative Study Registry
Principal Investigator: Gary M. Lum, MD
Source: Sandoz Drug Company
Term: 1990-Continuous
A Controlled Trial of Steroid Withdrawal in Pediatric Renal Transplant Recipients
Principal Investigator: Gary M. Lum, MD
Source: National Institutes of Health - A106134
Term: 1994-Indefinite
National American Pediatric Renal Transplant Cooperative Study
Chronic Renal Insufficiency; OKT3 Induction; Sirolimus (Rapamycin) in Renal Transplant; and Growth Hormone in Pediatric Dialysis Patients
Principal Investigators: Gary M. Lum, MD, and Douglas M. Ford, MD
Source: Sandoz Pharmaceuticals, Genentech, Inc. and National Institutes of Health
Term: 1997-2002
1999-2000
Evaluation of Aquaporin 2 Excretion in Disorders of Water Balance
Principal Investigator: Melissa A. Cadnapaphornchai, MD
Source: National Institutes of Health, Clinical Investigator Development Award
Term: 2000-2002
Alternate Day Steroids in Children with IgA Nephropathy
Principal Investigator: Douglas M. Ford, MD
Source: National Institutes of Health, Clinical Investigator Award
Term: 1993-2000
Synsorb Pk in Children with E.coli-Associated Hemolytic Uremic Syndrome
Principal Investigator: Douglas M. Ford, MD
Source: Synsorb Biotech and National Institutes of Health
Term: 1997-2001
Recombinant Human Growth Hormone - Treatment of Growth Failure Associated with Chronic Renal Insufficiency in Children
Principal Investigators: Gary M. Lum, MD, and Douglas M. Ford, MD
Source: Genentech Drug Company
Term: 1991-2000
Controlled Trial of Induction Therapy in Renal Transplantation
Principal Investigator: Gary M. Lum, MD
Source: National Institutes of Health
Term: 1994-Indefinite
North American Pediatric Renal Transplant Collaborative Study Registry
Principal Investigator: Gary M. Lum, MD
Source: Sandoz Drug Company
Term: 1990-Continuous
National American Pediatric Renal Transplant Cooperative Study
Chronic Renal Insufficiency; OKT3 Induction; Sirolimus (Rapamycin) in Renal Transplant; and Growth Hormone in Pediatric Dialysis Patients
Principal Investigators: Gary M. Lum, MD and Douglas M. Ford, MD
Source: Sandoz Pharmaceuticals, Genentech, Inc. and National Institutes of Health
Term: 1997-2002
|
|
